A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(26 sites)

United States

Tucson Clinical Research Institute, Tucson, Arizona

Encompass Clinical Research, Spring Valley, California

University Clinical Investigators, Inc., Tustin, California

Tampa Bay Medical Research, Clearwater, Florida

Encore Medical Research, Hollywood, Florida

Clinical Research of Central Florida, Lakeland, Florida

Encore Medical Research - Weston, Weston, Florida

Iowa Diabetes and Endocrinology Research Center, West Des Moines, Iowa

Washington University School of Medicine, St Louis, Missouri

Accellacare - Wilmington, Wilmington, North Carolina

AMR Clinical, Norman, Oklahoma

Tribe Clinical Research, LLC, Greenville, South Carolina

Holston Medical Group, Bristol, Tennessee

Texas Diabetes & Endocrinology, P.A., Austin, Texas

Velocity Clinical Research, Dallas, Dallas, Texas

Juno Research, Houston, Texas

Southern Endocrinology Associates, Mesquite, Texas

Consano Clinical Research, LLC, Shavano Park, Texas

Texas Valley Clinical Research, Weslaco, Texas

Chrysalis Clinical Research, St. George, Utah

Argentina

CIPREC, Buenos Aires

Mautalen Salud e Investigación, Buenos Aires

Consultorio de Investigación Clínica EMO SRL, Buenos Aires

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, Buenos Aires

Instituto Centenario, CABA

Instituto Médico Catamarca IMEC, Rosario